DANBURY, Conn., Aug. 15, 2011 /PRNewswire/ -- Biodel Inc. (Nasdaq: BIOD) today announced that management will be presenting at the Wedbush 2011 Life Sciences Conference in New York. The presentation is scheduled for Tuesday, August 16 at 2:25 p.m. EDT ( 11:25 a.m. PDT). To listen to the live webcast or a replay of the presentation, please visit the Investors section of the company's website at www.biodel.com. A replay will be available for 90 days after the event.
About Biodel Inc.
Biodel Inc. is a specialty biopharmaceutical company focused on the development and commercialization of innovative treatments for diabetes that may be safer, more effective and more convenient for patients. We develop our product candidates by applying our proprietary formulation technologies to existing drugs in order to improve their therapeutic profiles. For further information regarding Biodel, please visit the company's website at www.biodel.com.
BIOD-GContact: Seth D. Lewis, +1-646-378-2952SOURCE Biodel Inc.